Retour
MoonLake Immunotherapeutics (MLTX) Gagner
Graphique du cours de l'action MLTX
MLTX Gagner
MoonLake Immunotherapeutics
$16.93
-2.25%
$-0.39
À la fermeture : Mar 30, 16:00:00 GMT-4
$16.74
-1.12%
$-0.19
Post-Marché: Mar 30, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$17.32
Prix d'ouverture
$17.26
Plage de la journée
$16.41 - $17.67
Plage de 52 semaines
$5.95 - $62.75
Volume
1.3M
Volume moyen
1.9M
Rendement en dividend
--
BPA (TTM)
-3.52
Capitalisation boursière
$1.2B
Qu’est-ce que MLTX ?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.